Medical Oncology

Doç. Dr. Umut Dişel

Doctor and researcher Acıbadem Adana Hastanesi Adana
NeoplasmsLymphoma, Non-HodgkinLeukemia, Myeloid, AcuteStomach NeoplasmsLung NeoplasmsLeukemiaLeukemia, Lymphocytic, Chronic, B-CellAdenocarcinomaBreast NeoplasmsOvarian NeoplasmsCarcinoma, Non-Small-Cell LungDrug HypersensitivityBile Duct NeoplasmsCholangiocarcinomaLymphoma, FollicularNeutropeniaLeukemia, Promyelocytic, AcuteHodgkin DiseaseSarcoidosis
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Neoplasms 8 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Lymphoma, Non-Hodgkin 4 publications
  • Leukemia, Myeloid, Acute 4 publications
  • Stomach Neoplasms 3 publications
  • Lung Neoplasms 3 publications
  • Leukemia 3 publications
  • Leukemia, Lymphocytic, Chronic, B-Cell 3 publications
  • Adenocarcinoma 2 publications
  • Breast Neoplasms 2 publications
  • Ovarian Neoplasms 2 publications
  • Carcinoma, Non-Small-Cell Lung 2 publications
  • Drug Hypersensitivity 2 publications
  • Bile Duct Neoplasms 2 publications
  • Cholangiocarcinoma 2 publications
  • Lymphoma, Follicular 2 publications
  • Neutropenia 2 publications
  • Leukemia, Promyelocytic, Acute 2 publications
  • Hodgkin Disease 2 publications
  • Sarcoidosis 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.

  • Akciğer, Akciğer Zarı Kanserleri (Mezotelyoma) ve Diğer Torasik Kanserler
  • Baş Boyun Kanserleri
  • Karaciğer Kanseri
  • Kemik Tümörleri
  • Kolorektal Kanserler (Kolon ve Rektum Kanseri)
  • Meme Kanseri
  • Mide Kanseri
  • Omurga ve Omurilik Tümörleri
  • Pankreas Kanseri
  • Prostat Kanseri
  • Jinekolojik Tümörler ve Kanserler (Rahim, Serviks, Yumurtalık/Over Kanseri vb.)
  • Lenfödem (Fil Hastalığı) Tedavisi
  • Testis Kanseri
  • Yumurtalık (Over) Kanseri
  • Sarkomlar (Yumuşak Doku ve Kemik Tümörleri)
  • Akciğer Kanseri
  • Kolon (Kalın Bağırsak) Kanseri
  • Omurga Tümörleri
  • Yumuşak Doku Sarkomları

CV

Education and experience

From source

Experience

  • 2018Acıbadem Sağlık Grubuacibadem.com.tr

Education

  • 2017Tıbbi Onkoloji / Doçent Doktor, Digeracibadem.com.tr
  • 2005Çukurova Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji, Üst Uzmanlıkacibadem.com.tr
  • 2001Çukurova Üniversitesi Tıp Fakültesi, İç Hastalıkları, Uzmanlıkacibadem.com.tr
  • 1995Çukurova Üniversitesi Tıp Fakültesi, Üniversiteacibadem.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyInternal Medicine, Medical Oncologyacibadem.com.trFrom source
  • Department name at the sourceİç Hastalıkları (Dahiliye)acibadem.com.trFrom source
  • InstitutionAcıbadem Adana Hastanesiacibadem.com.trFrom source
  • Area of workNeoplasmsExtracted from 8 publications · Model version —From source
  • Publications78 publicationsOpenAlexFrom source
  • Last synchronised4 November 2026 20:44https://www.acibadem.com.tr/doktor/umut-disel/acibadem.com.tr

Scientific work

Publications on Neoplasms

78 publications

  1. Lessons from Exceptional Responders with High-Grade Brain Tumors Treated with Precision Targeted Therapies

    Journal of Immunotherapy and Precision Oncology, 2026

    DOI 10.36401/jipo-25-34 PMID 41868199 Open-access full textSource: OpenAlex

  2. CYLD Mutations, PD-L1 and HPV; A Pan-Cancer Landscape Analysis

    Research Square, 2026

    DOI 10.21203/rs.3.rs-10854026/v1 PMID 42818505 Source: OpenAlex

  3. Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) study

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-09707-3 PMID 40653542 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  4. Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program

    BMC Cancer, 2025

    DOI 10.1186/s12885-025-15287-2 PMID 41275151 Open-access full textSource: OpenAlex

  5. Uniform Reporting of Next Generation Sequencing: Indian Society of Medical and Pediatric Oncology

    Indian Journal of Medical and Paediatric Oncology, 2025

    DOI 10.1055/s-0045-1806726 Source: OpenAlex

  6. Real-life efficacy and safety data of lorlatinib treatment in ROS-1–positive advanced non-small cell lung cancer: Turkish Oncology Group (TOG) study.

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.16_suppl.e20659 Source: OpenAlex

  7. Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study

    Cancers, 2024

    DOI 10.3390/cancers16122251 PMID 38927957 4 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. The value of virtual molecular tumor boards for informed clinical decision-making

    The Oncologist, 2024

    DOI 10.1093/oncolo/oyae077 PMID 38761380 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  9. Demographic and survival data of patients with primary diffuse large B-cell lymphoma of the head and neck: A single center experience.

    Journal of Clinical Oncology, 2024

    DOI 10.1200/jco.2024.42.16_suppl.e19069 Source: OpenAlex

  10. Increased KRAS G12C Prevalence, High Tumor Mutational Burden, and Specific Mutational Signatures Are Associated With MUTYH Mutations: A Pan-Cancer Analysis

    The Oncologist, 2023

    DOI 10.1093/oncolo/oyad230 PMID 37589222 4 citations (Europe PMC) Open-access full textSource: OpenAlex

View all 78 publications